Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dodel

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Der Nervenarzt|April 8, 2014
[Multimorbidity: concept, epidemiology and treatment]R Dodel
HNO|February 8, 2020
[Dementia: relevant aspects for otorhinolaryngologists]R Dodel, C Völter
Der Nervenarzt|February 13, 2009
[Innovative treatment approaches for Alzheimer's disease. Immunotherapy]R Dodel, M Bacher
Der Nervenarzt|September 19, 2014
[Prediction of Alzheimer's dementia]F Jessen, R Dodel
Pharmacopsychiatry|May 20, 2005
Successful treatment of sexual disinhibition in dementia with carbamazepine -- a case reportN Freymann, R Michael, R Dodel, et al.
Journal of Neurology|September 14, 2018
Quality of life in a German cohort of Parkinson's patients assessed with three different measuresM Balzer-Geldsetzer, J Klotsche, , et al.
Clinical Neuropathology|January 1, 1996
Mitochondrial changes in muscle phosphoglycerate kinase deficiencyJ M Schröder, R Dodel, J Weis, et al.
Der Nervenarzt|April 27, 2007
[Depression in Parkinson's disease. Assessment and treatment]S Brand, R Dodel, M Hautzinger, et al.
European Journal of Neurology|October 13, 2020
The economic benefit of timely, adequate, and adherence to Parkinson's disease treatment: the Value of Treatment Project 2R Dodel, M Tinelli, G Deuschl, et al.
Neuroscience Letters|November 17, 2001
Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neuronsS Lin, Y Zhang, R Dodel, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Der Nervenarzt|April 8, 2014
[Multimorbidity: concept, epidemiology and treatment]R Dodel
HNO|February 8, 2020
[Dementia: relevant aspects for otorhinolaryngologists]R Dodel, C Völter
Der Nervenarzt|February 13, 2009
[Innovative treatment approaches for Alzheimer's disease. Immunotherapy]R Dodel, M Bacher
Der Nervenarzt|September 19, 2014
[Prediction of Alzheimer's dementia]F Jessen, R Dodel
Pharmacopsychiatry|May 20, 2005
Successful treatment of sexual disinhibition in dementia with carbamazepine -- a case reportN Freymann, R Michael, R Dodel, et al.
Journal of Neurology|September 14, 2018
Quality of life in a German cohort of Parkinson's patients assessed with three different measuresM Balzer-Geldsetzer, J Klotsche, , et al.
Clinical Neuropathology|January 1, 1996
Mitochondrial changes in muscle phosphoglycerate kinase deficiencyJ M Schröder, R Dodel, J Weis, et al.
Der Nervenarzt|April 27, 2007
[Depression in Parkinson's disease. Assessment and treatment]S Brand, R Dodel, M Hautzinger, et al.
European Journal of Neurology|October 13, 2020
The economic benefit of timely, adequate, and adherence to Parkinson's disease treatment: the Value of Treatment Project 2R Dodel, M Tinelli, G Deuschl, et al.
Neuroscience Letters|November 17, 2001
Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neuronsS Lin, Y Zhang, R Dodel, et al.
Pageof 3